Donald Trump & Eli Lilly and Company
23 shared events · Importance 4 · Last updated Jul 22, 2026
Live sentiment trends, interaction importance charts, and action volume tracking available on the
Ergen Dashboard
International
Donald Trump: As the US President, Donald Trump's approval is the final hurdle for any ceasefire extension or broader agreement with Iran. His stance on sanctions, nuclear issues, and the Strait of Hormuz significantly influences the negotiations.
Eli Lilly and Company: Eli Lilly and Company>>> advanced after CVS Health>>> announced it would restore coverage for its weight-loss injection, Zepbound, and add its new obesity pill Foundayo.
May 18, 2026 · 309 articles
Domestic
Donald Trump: Donald Trump's comments about a potential end to the Middle East conflict influenced market sentiment, leading to speculation about peace.
Eli Lilly and Company: Eli Lilly and Company rose after the United States — Food and Drug Administration approved its new weight loss pill, Foundayo.
Apr 01, 2026 · 14 articles
International
Donald Trump: Donald Trump, as the US President, needs to approve the tentative ceasefire extension and nuclear deal. His decisions are crucial for the finalization of the agreement and the lifting of sanctions.
Eli Lilly and Company: Eli Lilly and Company>>> advanced after CVS Health>>> announced it would restore coverage for its weight-loss injection, Zepbound, and add its new obesity pill Foundayo.
May 27, 2026 · 101 articles
Domestic
Donald Trump: Donald Trump announced new tariffs on various imported goods, aiming to boost domestic manufacturing and reduce the budget deficit, despite warnings of increased inflation and harm to consumers.
Eli Lilly and Company: Eli Lilly and Company, among other pharmaceutical companies, had previously announced investments in U.S. production due to the threat of tariffs, but the new, higher tariffs introduce further uncertainty.
Sep 26, 2025 · 7 articles
Business
Donald Trump: President Donald Trump's statements regarding potential attacks on Iran and the possibility of a peace deal influenced market sentiment and oil prices.
Eli Lilly and Company: Eli Lilly and Company>>> advanced after positive trial results for its next-generation obesity drug, retatrutide, which showed benefits beyond weight loss.
May 20, 2026 · 72 articles
Domestic
Donald Trump: Donald Trump>>> announced the expansion of TrumpRx, a key initiative of his administration to lower drug prices for United States>>> consumers.
Eli Lilly and Company: Eli Lilly and Company>>> is one of the pharmaceutical companies participating in the TrumpRx program, agreeing to reduce prices on certain medications.
Jun 06, 2026 · 8 articles
Business
Donald Trump: President Trump signed an executive order in April 2026 to accelerate research and patient access to psychedelic medicines, providing regulatory tailwinds for the sector.
Eli Lilly and Company: Eli Lilly is the acquirer, paying $2.8B upfront for Atai Life Sciences to bolster its neuroscience pipeline and diversify beyond its weight-loss drug franchise. The deal is part of a broader acquisition spree funded by strong commercial performance.
Jul 16, 2026 · 25 articles
Business
Donald Trump: Threatened major strikes on Iran; appointed Kevin Warsh as Fed chair.
Eli Lilly and Company: Eli Lilly's stock jumped after a committee of the European Medicines Agency recommended one of its medicines for approval, boosting its market performance.
Apr 20, 2026 · 344 articles
International
Donald Trump: Trump is seeking a deal to end the war and ease oil prices. He has signaled optimism but also threatened strikes, creating uncertainty.
Eli Lilly and Company: Eli Lilly and Company raised its forecast, boosting healthcare stocks. It is not connected to the event.
Mar 09, 2018 · 316 articles
Domestic
Donald Trump: President Donald Trump has expressed little anxiety about AI displacing human workers, focusing instead on AI-related investments driving economic growth and job availability.
Eli Lilly and Company: Eli Lilly is an employer involved in the RaiseMe project, contributing to the nonprofit's goal of adapting the workforce to an AI economy.
Jun 25, 2026 · 7 articles
Regulatory
Eli Lilly and Company: Eli Lilly and Company agreed to lower prices for its obesity drug Zepbound and will sell a starter dose for $299 a month, with additional doses up to $449, representing $50 reductions from current direct-to-patient prices. Its sales of Zepbound have tripled this year to over $9 billion.
Nov 06, 2025 · 6 articles
Domestic
Eli Lilly and Company: Eli Lilly and Company saw gains that helped offset drops in other sectors, contributing to the overall positive market performance.
Dec 11, 2025 · 7 articles
Business
Eli Lilly and Company: Eli Lilly and Company faces increased competition with Novo Nordisk's Wegovy pill launch, potentially impacting its market dominance in weight-loss drugs. Its shares fell following the announcement.
Jan 05, 2026 · 7 articles
Business
Eli Lilly and Company: Eli Lilly and Company is mentioned as one of the companies that SpaceX's valuation will surpass, emphasizing the magnitude of SpaceX's market entry.
Mar 09, 2018 · 538 articles
ERGEN INTELLIGENCE
Explore this relationship live
Track how Donald Trump and Eli Lilly and Company interact across events, view sentiment trends, and discover connected entities.
Open Dashboard